Companies formed
Since 1987, Oxford University Innovation has been responsible for creating spinout companies based on academic research generated within and owned by the University of Oxford, and in recent years has spun out 15-20 new companies every year.
Over £2.5bn in external investment has been raised by Oxford University Innovation spinouts since 2010, and ten of our current portfolio are currently listed in London and New York.
The creation of new spinout companies, most of which are listed below, also channels millions of pounds back into University research, benefits local economic development and has created many new jobs in the region.
1928 Foundation
OxProx
Lumai
Optical neural networks.
Incorporated in January 2022
Origin: Oxford University, Department of Physics
2021
OxDx
Human Centric DD
To discover significantly de-risked novel drug targets for licensing and in-house development.
Incorporated in December 2021
Origin: Oxford University, Nuffield Department of Clinical Medicine
Alethiomics
Reg Metrics
Reg Metrics - Regulatory compliance software, that enables health innovation.
Incorporated in November 2021
Origin: Oxford University, Department of Engineering Science
Nature-based Insetting
Social enterprise focusing on assessment of the ecological impact of industry supply chain and manufacturing and associated remedations.
Incorporated in November 2021
Origin: Oxford University, Department of Zoology
OxCarbon
RQ Biotechnology
RAIQC
Software to train radiologists.
Incorporated in October 2021
Origin: Oxford University, Oncology
QuantrolOx
OxCCU
Sandymount
EndLyz Therapeutics Inc
The company has been created by the Dementia Discovery Fund. The Company’s mission is to develop disease-modifying therapeutics that restore endo-lysosomal function and abrogate neurodegeneration in Parkinson’s disease and other dementias.
Origin: Oxford University, Department of Physiology, Anatomy and Genetics
Amber Therapeutics
LiliumX
LiliumX uses a unique protein technology platform to facilitate scalable discovery of first-in-class bispecific biologics
Incorporated in May 2021
Origin: Oxford University, Department of Biochemistry
Oxford Green Innotech
Carbon-free transformation of ammonia waste.
Incorporated in March 2021
Origin: Oxford University, Department of Chemistry
OxVax
The technology consists of two patent families which collectively enable the development of cost effective, off-the-shelf vaccines based on a proprietary dendritic cell subset for the treatment of solid tumour cancers. The technology overcomes certain key roadblocks previously associated with dendritic cell vaccine technology.
Incorporated in March 2021
Origin: Oxford University, Sir William Dunn School of Pathology
Curacode
Cutting edge laser technology company.
Incorporated in February 2021
Origin: Oxford University, Department of Engineering Science